Return to search results.
Complete title: A Phase 3, Randomized, Open Label Trial of Lenalidomide/Dexamethasone with or without Elotuzumab in Subjects with Previously Untreated Multiple Myeloma
|Research Study Number||2521.00|
|Principal Investigator||Bill Bensinger, MD|
Research Study Description
Eligibility Criteria (must meet the following to participate in this study)
Other eligibility criteria may apply.
Hematologic Malignancies; Multiple Myeloma (MM)
Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.